C69.62 Malignant neoplasm of left orbit

✓ Billable ICD-10-CM 2026
Open C69.62 in the app →

Get what a quick lookup can't: the AI assistant for official-guideline questions, HCC risk-adjustment mappings (CMS-HCC V24/V28, RxHCC), FDA drug indications, and AHA Coding Clinic references for C69.62.

The ICD-10-CM code for Malignant neoplasm of left orbit is C69.62 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
C69-C72: Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)
Category C69
37 codes (27 billable)
FY2026 Status
Stable since FY2024

U.S. Hospital Utilization

  • An estimated 320 U.S. inpatient stays in 2023 included C69.62 among the documented diagnoses.
  • 100 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Cite This Page

Reference C69.62 with the canonical source and edition:

C69.62 — Malignant neoplasm of left orbit. ICD-10 Coding Pro (ICD-10-CM FY2026). https://icd10codingpro.com/codes/C69.62

Canonical URL: https://icd10codingpro.com/codes/C69.62

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial